April 4, 2020 / 5:33 AM / 4 months ago

BRIEF-Novo Nordisk Says Rybelsus approved for treatment of adults with type 2 diabetes in EU

April 4 (Reuters) - Novo Nordisk A/S:

* NOVO NORDISK - EUROPEAN COMMISSION GRANTED MARKETING AUTHORISATION FOR RYBELSUS FOR TREATMENT OF ADULTS WITH INSUFFICIENTLY CONTROLLED TYPE 2 DIABETES

* NOVO NORDISK SAYS LAUNCH OF RYBELSUS EXPECTED TO TAKE PLACE IN FIRST EU COUNTRIES IN SECOND HALF OF 2020. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below